|
BIOLASE, INC.
Schedule II — Consolidated Valuation and Qualifying Accounts and Reserves
For the Years Ended December 31, 2019, 2018, and 2017
(in thousands)
|
|
|
Balance at |
|
|
Charges |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning |
|
|
(Reversals) to Cost |
|
|
|
|
|
|
Balance at |
|
|
|
|
of Year |
|
|
or Expenses |
|
|
Deductions |
|
|
End of Year |
|
|
Year Ended December 31, 2019: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
850 |
|
|
$ |
1,827 |
|
|
$ |
(146 |
) |
|
$ |
2,531 |
|
|
Allowance for sales returns |
|
|
210 |
|
|
|
— |
|
|
|
— |
|
|
$ |
210 |
|
|
Allowance for tax valuation |
|
|
46,967 |
|
|
|
6,366 |
|
|
|
(111 |
) |
|
$ |
53,222 |
|
|
Year Ended December 31, 2018: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
802 |
|
|
$ |
469 |
|
|
$ |
(421 |
) |
|
$ |
850 |
|
|
Allowance for sales returns |
|
|
210 |
|
|
|
— |
|
|
|
— |
|
|
|
210 |
|
|
Allowance for tax valuation |
|
|
40,866 |
|
|
|
6,101 |
|
|
|
— |
|
|
|
46,967 |
|
|
Year Ended December 31, 2017: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
$ |
1,209 |
|
|
$ |
(401 |
) |
|
$ |
(6 |
) |
|
$ |
802 |
|
|
Allowance for sales returns |
|
|
210 |
|
|
|
— |
|
|
|
— |
|
|
|
210 |
|
|
Allowance for tax valuation |
|
|
54,310 |
|
|
|
(13,444 |
) |
|
|
— |
|
|
|
40,866 |
|
|